| 2023年年报 | 2023年三季报 | |
|---|---|---|
| 营业收入(元) | ||
| 表观调控组学(元) | 39,685,143.77 | 26,775,264.73 |
| 蛋白与代谢组学(元) | 33,577,069.87 | 22,943,003.97 |
| 翻译转录组学(元) | 172,901,538.53 | 112,670,952.92 |
| 微生物与基因组学(元) | 29,744,646.20 | 20,159,369.63 |
| 其他(元) | 10,680,244.48 | 8,047,601.96 |
| 营业成本(元) | ||
| 表观调控组学(元) | 10,276,108.36 | 7,293,846.94 |
| 蛋白与代谢组学(元) | 19,808,215.21 | 13,695,922.62 |
| 翻译转录组学(元) | 90,337,241.11 | 57,496,963.40 |
| 微生物与基因组学(元) | 11,851,803.13 | 8,526,068.17 |
| 其他(元) | 6,025,856.70 | 4,211,514.17 |
| 毛利(元) | ||
| 表观调控组学(元) | 29,409,035.41 | 19,481,417.79 |
| 蛋白与代谢组学(元) | 13,768,854.66 | 9,247,081.35 |
| 翻译转录组学(元) | 82,564,297.42 | 55,173,989.52 |
| 微生物与基因组学(元) | 17,892,843.07 | 11,633,301.46 |
| 其他(元) | 4,654,387.78 | 3,836,087.79 |
| 毛利率(%) | ||
| 表观调控组学(%) | 74.11 | 72.76 |
| 蛋白与代谢组学(%) | 41.01 | 40.30 |
| 翻译转录组学(%) | 47.75 | 48.97 |
| 微生物与基因组学(%) | 60.15 | 57.71 |
| 其他(%) | 43.58 | 47.67 |
| 收入构成(%) | ||
| 表观调控组学(%) | 13.85 | 14.05 |
| 蛋白与代谢组学(%) | 11.72 | 12.04 |
| 翻译转录组学(%) | 60.33 | 59.12 |
| 微生物与基因组学(%) | 10.38 | 10.58 |
| 其他(%) | 3.73 | 4.22 |
| 毛利构成(%) | ||
| 表观调控组学(%) | 19.83 | 19.60 |
| 蛋白与代谢组学(%) | 9.29 | 9.31 |
| 翻译转录组学(%) | 55.68 | 55.52 |
| 微生物与基因组学(%) | 12.07 | 11.71 |
| 其他(%) | 3.14 | 3.86 |